Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03256981
PHASE2/PHASE3

Stereotactic Body Radiotherapy for the Treatment of OPD

Sponsor: Institute of Cancer Research, United Kingdom

View on ClinicalTrials.gov

Summary

HALT is a phase II, randomised multi-centre study with integrated seamless continuation to phase III trial following acceptable safety and feasibility assessment. HALT aims to recruit 110 patients with mutation positive advanced NSCLC with oligoprogressive disease (OPD) following initial response to a Tyrosine Kinase Inhibitor (TKI).

Official title: Targeted Therapy With or Without Dose Intensified Radiotherapy for Oligo-progressive Disease in Oncogene-addicted Lung Tumours

Key Details

Gender

All

Age Range

16 Years - Any

Study Type

INTERVENTIONAL

Enrollment

113

Start Date

2017-11-27

Completion Date

2027-06-30

Last Updated

2026-11-05

Healthy Volunteers

No

Conditions

Interventions

RADIATION

SBRT

SBRT dose and fractionation dependent on site of metastasis and proximity to critical normal tissues.

DRUG

TKI

Continued background TKI alone

Locations (29)

Institut Gustave Roussy

Paris, France

Institut Claudius Régaud

Toulouse, France

Policlinico Universitario Campus Bio-Medico

Roma, Italy

Ospedale San Luigi Gonzaga - Universita Di Torino

Torino, Italy

Hospital Clinic Universitari de Barcelona

Barcelona, Spain

Institut Català d'Oncologia

Barcelona, Spain

University Hospital Virgen del Rocio

Seville, Spain

Oncology Institute of Southern Switzerland

Bellinzona, Switzerland

Hopital Cantonal Universitaire De Geneve

Geneva, Switzerland

Kantonsspital St. Gallen

Sankt Gallen, Switzerland

UniversitatsSpital Zurich

Zurich, Switzerland

Royal Marsden Hosital

Sutton, England, United Kingdom

Royal Marsden Hospital

Chelsea, London, United Kingdom

Royal Surrey County Hospital

Guildford, Surrey, United Kingdom

Belfast City Hospital

Belfast, United Kingdom

Bristol Haematology and Oncology Centre

Bristol, United Kingdom

Western General Hospital

Edinburgh, United Kingdom

Beatson West of Scotland Cancer Centre

Glasgow, United Kingdom

Castle Hill Hospital

Hull, United Kingdom

Leicester Royal Infirmary

Leicester, United Kingdom

St Bartholomew's Hospital

London, United Kingdom

University College London Hospital

London, United Kingdom

Guy's Hospital

London, United Kingdom

The Christie Hospital

Manchester, United Kingdom

Clatterbridge Cancer Centre

Metropolitan Borough of Wirral, United Kingdom

Nottingham City Hospital

Nottingham, United Kingdom

Churchill Hospital

Oxford, United Kingdom

Weston Park Hospital

Sheffield, United Kingdom

Southampton University Hospital

Southampton, United Kingdom